肝脏X受体:在脱髓化疾病中是一种治疗点
Jule Richartz1, Sammie C Yam2, Na Zhan3
1Department of Neuroscience, Biomedical Research Institute, Hasselt University, Agoralaan building D, Diepenbeek 3590, Belgium.
Pharmacological research
|July 22, 2025
概括
肝脏X受体 (LXRs) 促进髓修复和神经元健康. 激活LXRs为消除多发性硬化症和阿尔茨海默病等脱髓化疾病提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝X受体 (LXR) 是调节脂质和胆固醇代谢的核受体.
- LXR激活与髓合成和维护有关.
- 神经退行性疾病中髓的丧失需要重新髓化疗法.
研究的目的:
- 审查LXR途径在复髓化策略中的作用.
- 探索LXR激动剂在脱髓化疾病中的治疗潜力.
主要方法:
- 对LXR激活和复髓化研究的文献综述.
- 对药理和天然LXR激动剂的分析.
主要成果:
- 激活LXR促进胆固醇的循环,并减少炎症.
- 直接的LXR激活通过诱导髓基因来增强回髓化.
- LXR激动剂显示了神经保护和复髓化潜力.
结论:
- LXR通路是促进复髓化的一种可行的治疗点.
- 药理和天然LXR激活剂可能为脱髓化疾病提供新的治疗方法.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K
Transducer Mechanism: Nuclear Receptors
1.6K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K


